Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.
about
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for maintenance of remission in ulcerative colitisAminosalicylates for induction of remission or response in Crohn's diseaseAminosalicylates for induction of remission or response in Crohn's diseaseReview article: aminosalicylates in inflammatory bowel disease.Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.Treatment of inflammatory bowel disease: a review of medical therapy.Prodrugs for amines.Synthesis of azobenzenes: the coloured pieces of molecular materials.Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews.Prodrugs design based on inter- and intramolecular chemical processes.Oxidative dehydrogenative couplings of pyrazol-5-amines selectively forming azopyrroles.Refractory ulcerative colitis treatmentWhat is the optimal therapy for severe ulcerative colitis?Dehydrogenation of the NH-NH Bond Triggered by Potassium tert-Butoxide in Liquid Ammonia.Mesoporous Manganese Oxide Catalyzed Aerobic Oxidative Coupling of Anilines To Aromatic Azo Compounds.
P2860
Q24185774-EBEC1138-DB42-446D-824A-CDDB90A9EEB2Q24185876-52B8DA69-EF30-4C69-A7B3-2B776198E63DQ24198024-8E48B827-7883-4748-8C6B-3C459B3E7B4AQ24198786-E6A95134-0C1B-474A-93F1-97CB59CF8737Q24235730-C97BE0BC-5E28-46A5-9A2F-3CDA03BBD6E5Q26471183-4F64FA7A-0471-4517-9329-77E9AF39DE47Q35880396-ECE2FA09-2A15-4EE5-9575-0196992CF6F2Q36589413-B0282B34-34F5-481F-A582-89730EF04F80Q37058862-B170D38E-208E-44C1-AF2D-CA76344A11BBQ37157240-26EF3755-C855-421C-AF21-C93E778D4419Q37853435-3700B2A0-8B6E-46D8-B288-F1C61A3B4385Q38118053-989E8E2C-21D3-4453-9743-FE3D267013CAQ38133663-EA0EFC6F-DB73-44B7-B279-631D8731A2D9Q39495129-AFECC359-1D64-482B-B311-3AE646C151ACQ42106968-60990215-1F1C-4A4F-89CC-C51C255574CCQ46347432-FA9FD743-A2C4-41CD-8C03-7AA332F243ABQ48907592-37B0BAC1-94AA-4912-A9E0-06EA7AA49732Q51568772-59B18ADA-B71E-4CA9-BD60-A57F57D42A24
P2860
Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@en
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@nl
type
label
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@en
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@nl
prefLabel
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@en
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@nl
P2860
P1476
Rational selection of oral 5-a ...... eatment of ulcerative colitis.
@en
P2093
William J Sandborn
P2860
P304
P356
10.1111/J.1572-0241.2002.07092.X
P407
P577
2002-12-01T00:00:00Z